Showing results (61-70 of 133) with videos related to
Sort By:
Pageof 14
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 14, 2023
Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysisKensuke Shoji, Yusuke Asai, Takayuki Akiyama, et al.Clinical Journal of Gastroenterology|June 2, 2025
IL-17A inhibitor-induced ulcerative colitis treated with an anti-IL-23 antibodyNatsuki Ishida, Yusuke Asai, Tomohiro Takebe, et al.BMJ Open|June 16, 2021
Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in JapanMari Terada, Hiroshi Ohtsu, Sho Saito, et al.Journal of Diabetes Investigation|January 28, 2023
Association of acute-to-chronic glycemic ratio and outcomes in patients with COVID-19 and undiagnosed diabetes mellitus: A retrospective nationwide cohort studyMasaki Uchihara, Takehiro Sugiyama, Ryotaro Bouchi, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 6, 2022
Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccinationNobumasa Okumura, Sho Saito, Yuki Takamatsu, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 22, 2023
Characteristics of hospitalized COVID-19 patients with other respiratory pathogens identified by rapid diagnostic testMichiyo Suzuki, Kayoko Hayakawa, Yusuke Asai, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 7, 2026
Comparison of Changes in Biomarkers With Changes in Endoscopic Scores in Patients With Ulcerative Colitis: A Single-Center, Retrospective, Observational StudyYosuke Yamada, Natsuki Ishida, Tomohiro Takebe, et al.Medicine|April 12, 2024
Ustekinumab effectiveness in Crohn's disease with lesions in the intestinesSatoshi Tamura, Yusuke Asai, Natsuki Ishida, et al.Plos One|January 2, 2024
Albumin change predicts failure in ulcerative colitis treated with adalimumabNatsuki Ishida, Kenichi Takahashi, Yusuke Asai, et al.Open Forum Infectious Diseases|January 23, 2023
Statistical Analysis of Mortality Rates of Coronavirus Disease 2019 (COVID-19) Patients in Japan Across the 4C Mortality Score Risk Groups, Age Groups, and Epidemiological Waves: A Report From the Nationwide COVID-19 CohortHiroaki Baba, Saori Ikumi, Shotaro Aoyama, et al.Pageof 14